tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
Advertisement

Oncopeptides AB (ONCO) Stock Forecast & Price Target

Compare
5 Followers
See the Price Targets and Ratings of:

ONCO Financial Forecast

ONCO Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

ONCO Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on SE:ONCO
TR | OpenAI - 4o
TR | OpenAI - 4o
kr6.5kr5
Hold
23.76%
Upside
Reiterated
08/06/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on SE:ONCO
TR | OpenAI - 4o
TR | OpenAI - 4o
kr6.5kr5
Hold
23.76%
Upside
Reiterated
08/06/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oncopeptides AB

1 Month
No data currently available
3 Months
No data currently available
1 Year
Dex GenotekTR | OpenAI - 4o
Success Rate
0/1 ratings generated profit
Average Return
-139.50%
downgraded a sell rating 3 months ago
Copying Dex Genotek's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of -139.50% per trade.
2 Years
No data currently available
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ONCO Analyst Recommendation Trends

Rating
Oct 21
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
1
1
13
13
Sell
1
1
2
1
1
Strong Sell
3
1
0
0
0
total
4
3
3
14
14
In the current month, ONCO has received 0 Buy Ratings, 13 Hold Ratings, and 1 Sell Ratings. ONCO average Analyst price target in the past 3 months is 5.00.
Each month's total comprises the sum of three months' worth of ratings.

ONCO Stock Forecast FAQ

What is SE:ONCO’s average 12-month price target, according to analysts?
Based on analyst ratings, Oncopeptides AB’s 12-month average price target is 5.00.
    What is SE:ONCO’s upside potential, based on the analysts’ average price target?
    Oncopeptides AB has 23.76% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Oncopeptides AB a Buy, Sell or Hold?
          Oncopeptides AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Oncopeptides AB’s share price target?
            The average share price target for Oncopeptides AB is 5.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr5.00 ,and the lowest forecast is kr5.00. The average share price target represents 23.76% Increase from the current price of kr4.04.
              What do analysts say about Oncopeptides AB?
              Oncopeptides AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Oncopeptides AB?
                To buy shares of SE:ONCO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis